The global DNA synthesis market is projected to grow by $6.5 billion from 2024 to 2028, driven by automation and demand for ...

Spanish biotech Integra Therapeutics has upped its arsenal of gene editing tools by licensing Caszyme’s Cas12I nucleases, the ...

Biotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 ...

Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies ... it back to the company for a detailed DNA analysis. But now the company is ...

When tested in mice, the compound—named BBI-2779—shrank gastric tumors and prevented the cancer from developing resistance to ...

Natera is Thursday's pick for IBD 50 Stocks To Watch as the biotech reclaims a critical chart level and serves up a fresh buy point. The DNA testing company is a holding of Cathie Wood's ARK Invest ...

DNA editing makes permanent changes to a person’s genome ... RNA editing is in its nascent stage, yet there are already at ...

If left unchecked, insect pests can devastate crops. To minimize damage and reduce the need for insecticide sprays, crops ...

modern biotechnology really began with the creation of recombinant DNA plasmids, which could be transferred into bacteria that would manufacture human proteins from the microbes’ coded genes.

Introduces DNA Expand Subscription Platform to Enrich Existing DNA Ancestry Data with Comprehensive Health Insights GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PRPH) (the “Company” or ...